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We conclude that only 1 hour of rapid pacing after 1 week of bradycardia is
sufficient to produce a change in myocardial responsiveness to the K+ chan-
nel blocker, CsCI, and increases the susceptibility of VT induction, possibly
via an increase in EAD amplitude.
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The mechanisms of ventricular fibrillation (VF) are unknown. Reentrant wave-
fronts have been shown to underlie the onset (Wiggers' stage I) of elec-
trically induced VF in intact canine ventricles. These reentrant wavefronts,
however, have a limited lifespan (1-2 s) while VF persists. Using computer-
ized mapping techniques, we studied the mechanism by which VF is main-
tained beyond the initial few seconds (Wiggers' stage II), both in normal and
subendocardium-ablated canine ventricles. Eleven open-chest dogs were
studied. In 6 of the dogs, the RV subendocardium was ablated with lugol's
solution. A plaque electrode array with 317-509 bipolar recording electrodes
was sutured on the RV epicardium. VF was induced by a strong premature
stimulus (S2)' Starting 2.5 s after the onset of VF, 2-5 s of data were ana-
lyzed. The activation patterns were visualized via dynamic display. Conven-
tional isochronal maps were also constructed. Of the 15 runs of VF in dogs
with intact ventricles, 3 episodes of reentrant wavefronts were detected. The
mean lifespan was 4.5 ± 2.1 rotations. The mean cycle length was 102.5 ±
isoproterenol (Iso) (0.1 mg!kg!min). Three dogs (1 at baseline, 2 during Iso)
developed sustained VT (SuVT) during programmed stimulation with up to 3
extrastimuli. After the last extrastimulus, the first beat of SuVT (T1) initiated in
the subendocardium by a focal mechanism, based on the absence of electri-
cal activity from the termination of the last extrastimulus to the initiation of T1
despite the presence of multiple intermediate electrode sites. Maintenance
of SuVT was also due to a focal mechanism arising in the subendocardium,
with a total activation time (TAT) of subsequent SuVT beats (99 ± 14 msec,
n = 61 that was comparable to that of initiating beats (85 ± 8 msec. n =
6, P = 0.08). There was no evidence of macroreentry. Episodes of SuVT (n
= 3) exhibited TATs of the last extrastimulus before SuVT (106 ± 11 msec)
and coupling intervals of T1 (196 ± 70 msec) that were comparable to those
observed in nonsustained VT (n = 3) (138 ± 26 msec, p = 0.19; 166 ± 26
msec, p = 0.59). Conduction delay during sinus rhythm in dogs with SuVT
(TAT 47 ± 5 msec, n = 10) was comparable to that in dogs without SuVT
(TAT 47 ± 4 msec, n = 10, P = 0.96) and was unchanged by Iso (TAT 50
± 4 msec, n = 7, p = 0.40). In the 2 dogs with inducible SuVT on Iso only,
TATs of the last extrastimulus (124 ± 22 msec) and of T1 (110 ± 36 msec) at
baseline were unchanged by infusion of Iso (108 ± 13 msec, p = 0.59; 79
± 1 msec, p = 0.49). Thus, inducible sustained VT in a model of ischemic
cardiomyopathy is due to a focal mechanism, as opposed to macroreentry,
and this focal mechanism is enhanced by tl-adrenergic stimulation.
Clinically, torsades de pointes (TdP) often occurs when the heart rate sud-
denly slows (eg. atrial fibrillation to sinus rhythm). We investigated whether
the dose of cesium chloride (CsCI) required to induce early afterdepolariza-
tions (EADs), the putative mechanism of TdP. and ventricular tachycardia (VT)
was different in dogs with a paced left ventricular cycle length (PCl) of 1,000
msec for a 1 week versus dogs with a PCl of 1,000 msec for 1 week and
500 msec for 1 hour prior to a PCl of 1,000 msec. All dogs had atrioventric-
ular (AV) block induced by radiofrequency ablation and were studied closed
chest. While recording surface ECG leads 1,11.111 and lVendocardlal monopha-
sic action potential (MAPl, CsCI was injected Incrementally (0.25, 0.5, 0.625,
0.75, 1.0 mM!1<g) until sustained VT was induced. In group 1 (n = 6), CsCI
was injected during PCl = 1,000 msec. In group 2 (n = 71, CsCI was injected
during PCl = 1,000 msec after PCl = 500 msec for 1 hour. In group 1, VT
was induced at 0.75 mM!1<g in 3 dogs and at 1.0 mM!1<g in 3 dogs. VT was
induced at 0.75 mM!1<g in all 7 dogs in group 2(p < 0.05). The area of EAD
as a percentage of lV MAP area (%EAD) in group 2 dogs exceeded that of
group 1 at 0.5, 0.625, 0.75 mM!kg.
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Sudden Heart Rate Speeding and Slowing Facilitates
the Inducibility of Ventricular Tachycardia in Dogs
Tadashi Satoh, Harold P. Pride, Douglas P. Zipes. Krannert Institute of Cardiology,
Indiana University School of Medicine, Indianapolis, IN
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Focal Mechanisms Underlying Sustained Ventricular
Tachycardia In Ischemic Cardiomyopathy
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2 gender-matched groups of subjects widely separated in age by 2 decades:
an older group (age 73 ± 4, n = 42) and a younger group (age 53 ± 7, n =
41), during graded 3 minute infusions of DOS at 5, 10, and 20 jLg!1<g!min,
We excluded subjects who were on cardioactive medications or who had
abnormal lV function or conduction defects, Results: HR responses of the
two groups were nearly identical at all doses. In contrast, SSP responses
differed markedly (see figure). With increasing DOS dose, the young had an
increase in SSP while the old had a progressive decrease in SBP (p < 0.01
by ANOVA), even after adjusting for higher resting SBP in the old. The SSP
response was not affected by wall motion or lV function. Conclusion: Aging
markedly alters the blood pressure but not the heart rate response to DOB.
These data may help explain the frequency of hypotension during DSE.
Conclusion: 1) There is no statistical difference in the hemodynamic re-
sponse to dobutamine in young versus elderly patients. 2) Elderly patients
undergoing dobutamine stress testing augment their CO by increasing HR
and SV, decreasing SVR and with no change in EDD. 3) This is in contrast
to that observed during CST. 4) Adequate heart rate response in the elderly
might be more important during dobutamine infusion than during CST.
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1807-41 Normal Hemodynamic Responses to Dobutamine
Infusion In the Elderly
Craig lampert, Herman D. Movsowitz, larry E. Jacobs, Alfred loli, Morris N. Kotler
Albert Einstein Medical Center. Philadelphia, PA
Elderly patients undergoing conventional exercise stress testing (CST) rely
predominantly on an increased preload (Starling mechanism) to augment
cardiac output (CO). In contrast, younger patients rely predominantly on an
increased heart rate (HR) and decreased systemic vascular resistance (SVR)
to augment CO. To determine normal physiologic hemodynamic responses
to incremental dobutamine Infusion in young «65 yo) as compared to elderly
(:::65 yo) patients, we analyzed the results of 50 consecutive patients with
normal regional wall motion and normal ejection fraction at rest. All patients
underwent 2-D echocardiography and continuous wave Doppler evaluation
of the left ventricular outflow tract (lVOT) during each stage of the dobu-
tamine infusion protocol. No patients developed regional wall motion abnor-
malities during dobutamine infusion. HR, velocity time integral (VTI) across
the lVOT and end diastolic dimensions (EDD) were recorded. Stroke volume
(SV = VTI x cross sectional area of lVOTl, CO (HR x SV) and SVR (80 x mean
arterial pressure -+- CO) were calculated. The mean % change from baseline
of HR, Sv. EDD, SVR and CO are shown:
Carolyn M. Johnson, Steven Pogwizd Washington University, St. Louis, MO
To define the mechanism of ventricular tachycardia (VT) induced by pro-
grammed electrical stimulation in the setting of congestive heart failure, 3-
dimensional cardiac mapping was performed in six dogs with ischemic car-
diomyopathy induced by multiple intracoronary embolizations with micro-
spheres. Ejection fraction (EF) progressively decreased from 54 ± 2 to 30 ±
5% (p < 0.005) after an average of 6 weekly embolizations. Four months later
(EF = 28 ± 5%), each dog underwent a thoracotomy with insertion of plunge-
needle electrodes into the heart under pentobarbital anesthesia. Continuous
recording from 232 intramural sites throughout the left and right ventricles
and the interventricular septum was performed during spontaneous rhythm
and during programmed stimulation in both the absence and presence of
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TH
813 ± 43
769 ± 14
409 ± 42'
642 ± 49,t
111 ± 36
159 ± 57*
LF15 HF15
NE uptake
133 ± 9
49 ± 11'
64 ± 8'
40 ± g,t
91 ± 28
189 ± 63
Baseline
LF10 HF10
Supine
CCF 19 ± 8 63 ± 9' 18 ± 5 54 ± 7 13±4 47 ± 8' 16± 6 49± 8
Normal 14 ± 6 68 ± 8 18 ± 6 58 ± 10 15± 6 70± 5 22 ± 9 55 ± 10
Stand
CCF 15 ± 7 66 ± 6 19 ± 7 46± 8 30± 10 51 ± 9 7 ± 5 31 ± 10
Normal 28 ± 9 55 ± 8 30 ± 9 42± 9 58± 10 27 ± 5 50 ± 12 17 ± 5
;514 mmHg
>14mmHg
Conclusion: This study demonstrates that the acute administration of
digoxin reduces cardiac NESP in patients with CHF and high LV filling pres-
sures. This reduction in cardiac sympathetic activity appears to be mediated
by a non-hemodynamic mechanism, since digoxin in the dose used in this
study did not cause changes in either the loading conditions or the contrac-
tile state of the LV
Values are mean ± SE. 'p < 005 vs. SHAM; t P < 0.05 vs. CHF
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Desipramine Attenuates the Cardiac Sympathetic
Nerve Terminal Abnormalities in Congestive Heart
Failure
Akita Yatani, Suzanne Y. Felten, Yoshihiro Himura, Michihiro Kashiki,
Chang-seng Liang University of Rochester Med. Ctr., Rochester, NY
All data expressed as mean ± SEM.·p ~ 0.016, by paired t test
We have shown that cardiac norepinephrine (NE) reuptake activity and tyro-
sine hydroxylase (TH), a rate-limiting enzyme for NE synthesis, are reduced in
congestive heart failure (CHF). To determine whether the changes of TH are
caused by neurotoxic effects of NE, we administered the neuronal uptake
inhibitor desipramine (OMI, 225 mg/day) to pacing-induced CHF and sham-
operated (SHAM) dogs for 6 weeks. CHF was characterized by tachycardia,
low aortic pressure, elevated left atrial pressure, decreased left ventricular
dP/dt and reduced cardiac output. OMI produced no hemodynamic effects.
The effects of OMI on left ventricular NE uptake activity (fmollmgl15 min)
and immunocytochemical TH profiles were:
LVEDP Cardiac NESP (pmollmin)
Results: LF & HF spectral power in normalized units (%); S ~ spontaneous
(mean ± SEM)
The effect of cardiac glycosides on cardiac sympathetic activity in congestive
heart failure (CHF) remains uncertain.
Methods: We measured total body and cardiac norepinephrine spillover
(NESP) using the norepinephrine isotope-dilution technique at baseline and
30 minutes after digoxin (0.25 mg iv). LV pressure, its first derivative (Millar),
and systemic BP were also measured before and after digoxin. We studied
15 patients with CHF; 5 with normal LV filling pressures (LVEOP :s 14, mean
9 ± 2 mmHg). and 10 with high LV filling pressures (LVEOP > 14. mean 26
±3 mmHg).
Results: The groups had similar baseline HR, BP. and LV +dP/dt. The high
LVEOP group had a lower EF (20 ± 2 vs 34 ± 2%, p < 0.05), a lower CI (1.7 ±
0.2 vs 2.8 ± 0.3 Llmin/m2 , p < 0.05), and higher mean PA pressures (31 ±4vs
14± 2 mmHg, p < 0.05} at baseline, as compared to the normal LVEOP group.
HR, BP. LVEOP, LV +dp/dt, coronary sinus blood flow, and total body NESP did
not change in either group following digoxin. Cardiac NESP was unchanged
in response to digoxin in the normal LVEOP group. Importantly, digoxin
caused a consistent reduction in cardiac NESP in the high LVEOP group:
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Effect of Digoxin on Cardiac Sympathetic Activity in
Congestive Heart Failure
Gary E. Newton, Jeffrey H. Tong, Anne M. Schofield, Andrew D. Baines, John
S. Floras, John D. Parker Mount Sinai Hospital, Toronto, Canada
'p < 0.05
Supine HF power falls with increasing respiratory rate in most CCF pts
and this effect is similar to that seen in normals on standing (I.e. at increased
sympathetic levels). An improvement in clinical state of CCF pts will lower
respiratory rate and this effect alone will increase HF power rather than any
therapy.
Group
SHAM In ~ 12)
SHAM + OMI (n = 6)
CHF In ~ 12)
CHF + OMI (n = 7)
Mean EG as %CLEGMin R-CMax R-B
104 ± 31 ms 124 ± 35 ms 29-49 ms 22-31 %
97 ± 21 ms 101 ± 25 ms 30-35 ms 23-30%
p = 0.28 p = 0.008
Group Mean R-C
5 Day 154 ± 29 ms
BWeek 132 ± 23 ms
p = 0.002
5.5 msec. The incidence of reentry was 0.018 ± 0.048 rotations/sec-em2. Of
the 18 runs of VF in dogs with ablated ventricles, 8 episodes of reentry were
detected. The mean lifespan was 3.6 ± 1.1 rotations (p = 0.39 compared
with intact ventricles). The mean cycle length was 107.2 ± 9.6 msec (p =
0.16). The incidence of reentry was 0.075 ± 0.097 rotations/sec-cm2 (p =
0.048). In both groups of dogs, dynamic displays of the activation patterns
demonstrate that the reentrant wavefronts spiral rather than follow a sim-
ple circular pathway. Conclusions: (a) reentrant wavefronts are consistently
present during Wiggers' stage II VF, (b) ablation of the subendocardium and
Purkinje fibers results in an increased incidence of reentrant wavefronts on
the epicardium, and (c) the reentrant wavefronts are compatible with spiral
waves of excitation.
The mean R-C at these sites was longer than the mean VFCL for all sites in
the 5 day group (mean VFCL 133 ± 22 ms at 5 days, 130 ± 15 ms at 8 weeks).
A trend toward a longer upper limit of EG was seen in the 5 day group (p =
0.08). In 29% of all sites (36% at 5 days, 20% at 8 weeks) a significant EG
(2:10 ms) was not present.
Conclusions: An excitable gap exists at most sites during VF in a canine
model of myocardial infarction, but is absent in a minority of sites. The gap
may be shorter in absolute duration in chronic infarction (8 weeks) than in
subacute infarction (5 days). although the proportion of cycle length occu-
pied by the EG is similar in both groups. The site to site heterogeneity in the
magnitude and presence of EG in infarcted myocardium has implications for
the use of pacing techniques to modulate VE
[808-41 The Presence and Duration of an Excitable Gap
During Ventricular Fibrillation in a Canine Model of
Myocardial Infarction
George Horvath, Nikhil Patel, Roger S. Damle, Sandeep Jam, Nikki S. Robinson,
Jeffrey J. Goldberger, Alan H. Kadish. Northwestern University Medical School,
Chicago,lL
An excitable gap (EG) occupying 50% of the cycle length has been reported
in a non-infarcted canine model of ventricular fibrillation (VF). To evaluate the
presence and duration of an EG in VF post infarction, we studied 9 mongrel
dogs at 5 days (n = 5) and 8 weeks (n = 4) post LAO ligation. VF induced
by programmed stimulation was recorded using an 8 by 14 electrode array
(2.5 mm interelectrode distance) over the infarcted area. The mean VF cycle
length (VFCL) was determined at each site. EG was determined by a wave-
front analysis propagation method. Sites at which both conduction and block
occurred on different cycles were analyzed. At each, the interval from each
activation to the subsequent blocked (R-B) or conducted (R-C) impulse was
recorded, along with the R-C interval immediately preceding. The recovery
period at each site was estimated as the range bounded by the maximal R-B
and minimal R-C. The EG was determined by the difference of the recovery
period and the mean R-C at each site. Results: Fifty eight sites were suitable
for analysis.
Results of analysis (Mean or mean ± standard deviation):
Power spectral analysis of heart rate variability is frequently used as an easy
non invasive method for assessing autonomic tone. However changes in res-
piratory rate are frequently ignored and these may have an important effect
on the measurements of spectral components, especially in heart failure. We
have assessed the effect of different respiratory rates (10, 15, 20 min-1 and
spontaneous) on low frequency (LF) and high frequency (HF) components
of HR variability in 11 heart failure pts (CCF) (EF ~ 40 ± 4%; 9 males) and 9
normal subjects (5 males).
4:00
Different Respiratory Rates Affect the Measurement
of Autonomic Tone by Power Spectral Analysis of
Heart Rate Variability In Patients with Heart Failure
John E. Sanderson, Dickens T.K. Yeung, Leata Y.C. Yeung, Richard L.G. Kay,
8rian Tomlinson, Luciano Bernardi 1, Kam S. Woo. Chinese University ofHong Kong:
1 University of Pavia, Italy
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